UCLA Health - Revision history

MesotheliomaSupport: Internal linking: added 5 wiki links

2026-02-20T20:56:18Z

Internal linking: added 5 wiki links

MesotheliomaSupport: Internal linking: added 7 wiki links

2026-02-20T20:53:21Z

Internal linking: added 7 wiki links

← Older revision		Revision as of 20:53, 20 February 2026
Line 11:		Line 11:
	! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA [[Mesothelioma]] Program		! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA [[Mesothelioma]] Program
	\|-		\|-
	\| colspan="2" style="padding:10px; text-align:center; font-style:italic; " \| First dedicated U.S. mesothelioma program		\| colspan="2" style="padding:10px; text-align:center; font-style:italic; " \| First dedicated U.S. [[Mesothelioma\|mesothelioma]] program
	\|-		\|-
	\| style="padding:10px; font-weight:bold; width:40%; border-bottom:1px solid #dee2e6; " \| Founded		\| style="padding:10px; font-weight:bold; width:40%; border-bottom:1px solid #dee2e6; " \| Founded
Line 122:		Line 122:
	== What Treatment Approaches Does UCLA Offer? ==		== What Treatment Approaches Does UCLA Offer? ==

	UCLA's mesothelioma program offers comprehensive multimodal treatment options, with a distinctive emphasis on lung preservation.<ref>[https://mesotheliomaattorney.com/mesothelioma/treatment/best-centers/ Top Mesothelioma Treatment Centers], Mesothelioma Attorney</ref>		UCLA's mesothelioma program offers comprehensive multimodal [[Treatment Options\|treatment options]], with a distinctive emphasis on lung preservation.<ref>[https://mesotheliomaattorney.com/mesothelioma/treatment/best-centers/ Top Mesothelioma Treatment Centers], Mesothelioma Attorney</ref>

	'''Surgical Options'''		'''Surgical Options'''
Line 151:		Line 151:
	== What Clinical Trials Can Patients Access? ==		== What Clinical Trials Can Patients Access? ==

	UCLA maintains an active clinical trials program, giving patients access to experimental therapies not yet available to the general public.<ref>[https://dandell.com/mesothelioma/ Mesothelioma], Danziger & De Llano</ref>		UCLA maintains an active [[Clinical Trials\|clinical trials]] program, giving patients access to experimental therapies not yet available to the general public.<ref>[https://dandell.com/mesothelioma/ Mesothelioma], Danziger & De Llano</ref>

	'''Current and Recent Trials'''		'''Current and Recent Trials'''
Line 162:		Line 162:

	'''MTG201 Plus Nivolumab:'''		'''MTG201 Plus Nivolumab:'''
	Study in patients with relapsed pleural mesothelioma, combining novel targeted therapy with established immunotherapy.		Study in patients with relapsed [[Pleural Mesothelioma\|pleural mesothelioma]], combining novel targeted therapy with established immunotherapy.

	'''MEDI4736 Studies:'''		'''MEDI4736 Studies:'''
Line 191:		Line 191:
	{\| style="width:95%; margin:1em auto; border-left:4px solid #1a5276; border-radius:4px;"		{\| style="width:95%; margin:1em auto; border-left:4px solid #1a5276; border-radius:4px;"
	\|-		\|-
	\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5; " \| "Veterans often don't realize they can pursue both VA benefits and legal compensation simultaneously. These are separate systems, and qualifying for one doesn't affect eligibility for the other."		\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5; " \| "Veterans often don't realize they can pursue both [[VA Benefits\|VA benefits]] and legal compensation simultaneously. These are separate systems, and qualifying for one doesn't affect eligibility for the other."
	\|-		\|-
	\| style="padding:5px 25px 20px; text-align:right; " \| '''— Rod De Llano,''' Founding Partner, Danziger & De Llano		\| style="padding:5px 25px 20px; text-align:right; " \| '''— Rod De Llano,''' Founding Partner, Danziger & De Llano
	\|}		\|}

	'''California Military Asbestos Exposure Sites'''		'''California Military [[Asbestos Exposure]] Sites'''

	California veterans may have been exposed to asbestos at numerous military installations, including:<ref>[https://www.mesotheliomalawyercenter.org/entity/hunters-point-naval-shipyard/ Hunters Point Naval Shipyard], Mesothelioma Lawyer Center</ref>		California veterans may have been exposed to asbestos at numerous military installations, including:<ref>[https://www.mesotheliomalawyercenter.org/entity/hunters-point-naval-shipyard/ Hunters Point Naval Shipyard], Mesothelioma Lawyer Center</ref>
Line 237:		Line 237:
	Mesothelioma treatment costs can exceed $400,000, creating significant financial stress for patients and families.<ref>[https://www.mesotheliomalawyercenter.org/determining-mesothelioma-and-asbestos-case-value/ Mesothelioma Case Values], Mesothelioma Lawyer Center</ref> Multiple resources exist to help offset these costs.		Mesothelioma treatment costs can exceed $400,000, creating significant financial stress for patients and families.<ref>[https://www.mesotheliomalawyercenter.org/determining-mesothelioma-and-asbestos-case-value/ Mesothelioma Case Values], Mesothelioma Lawyer Center</ref> Multiple resources exist to help offset these costs.

	'''Asbestos Trust Funds'''		'''Asbestos [[Trust Funds]]'''

	Over $30 billion remains available in 60+ asbestos bankruptcy trust funds established by companies that manufactured or used asbestos products.<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], Mesothelioma Attorney</ref> Many patients qualify for multiple trusts based on their exposure history:		Over $30 billion remains available in 60+ asbestos bankruptcy trust funds established by companies that manufactured or used asbestos products.<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], Mesothelioma Attorney</ref> Many patients qualify for multiple trusts based on their exposure history:

MesotheliomaSupport: Internal linking: added 8 wiki links

2026-02-20T20:46:53Z

Internal linking: added 8 wiki links

← Older revision		Revision as of 20:46, 20 February 2026
Line 9:		Line 9:
	{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"
	\|-		\|-
	! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA Mesothelioma Program		! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA [[Mesothelioma]] Program
	\|-		\|-
	\| colspan="2" style="padding:10px; text-align:center; font-style:italic; " \| First dedicated U.S. mesothelioma program		\| colspan="2" style="padding:10px; text-align:center; font-style:italic; " \| First dedicated U.S. mesothelioma program
Line 36:		Line 36:
	== Executive Summary ==		== Executive Summary ==

	The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma at UCLA Health], UCLA Health</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>		The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma at UCLA Health], UCLA Health</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their [[Asbestos Exposure\|asbestos exposure]] through [[Trust Funds\|trust funds]] and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

	== Key Facts ==		== Key Facts ==
Line 64:		Line 64:
	'''The Birth of Specialized Mesothelioma Care'''		'''The Birth of Specialized Mesothelioma Care'''

	In 1997, Dr. Robert Brian Cameron founded the Comprehensive Mesothelioma Program at UCLA, establishing what appears to be the first formally dedicated mesothelioma treatment program in the United States—predating even the internationally renowned program at Brigham and Women's Hospital by five years.<ref>[https://mesothelioma.net/robert-b-cameron-m-d/ Robert B. Cameron, M.D.], Mesothelioma.net</ref> This pioneering effort came at a time when mesothelioma was almost universally fatal and treatment options remained extremely limited.		In 1997, Dr. Robert Brian Cameron founded the Comprehensive Mesothelioma Program at UCLA, establishing what appears to be the first formally dedicated mesothelioma treatment program in the United States—predating even the internationally renowned program at Brigham and Women's Hospital by five years.<ref>[https://mesothelioma.net/robert-b-cameron-m-d/ Robert B. Cameron, M.D.], Mesothelioma.net</ref> This pioneering effort came at a time when mesothelioma was almost universally fatal and [[Treatment Options\|treatment options]] remained extremely limited.

	Dr. Cameron brought a deeply personal motivation to his work. After losing his father, grandfathers, one uncle, and two cousins to various cancers—all dying before age 55—he dedicated himself to extending patient lives while maintaining quality of life. His approach would challenge the prevailing surgical wisdom of the era.		Dr. Cameron brought a deeply personal motivation to his work. After losing his father, grandfathers, one uncle, and two cousins to various cancers—all dying before age 55—he dedicated himself to extending patient lives while maintaining quality of life. His approach would challenge the prevailing surgical wisdom of the era.
Line 113:		Line 113:
	* NIH-funded research laboratory at UCLA Jonsson Comprehensive Cancer Center		* NIH-funded research laboratory at UCLA Jonsson Comprehensive Cancer Center

	Dr. Burt's research focuses on response and resistance mechanisms to immunotherapy in thoracic malignancies. In 2021, he received a $2.5 million grant from the National Cancer Institute to fund ongoing biomarker testing to determine which pleural mesothelioma patients would benefit from immunotherapy.		Dr. Burt's research focuses on response and resistance mechanisms to immunotherapy in thoracic malignancies. In 2021, he received a $2.5 million grant from the National Cancer Institute to fund ongoing biomarker testing to determine which [[Pleural Mesothelioma\|pleural mesothelioma]] patients would benefit from immunotherapy.

	{\| style="width:100%; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"
Line 128:		Line 128:
	* '''Pleurectomy/Decortication (P/D):''' UCLA's signature procedure, removing the diseased pleural lining while preserving the lung		* '''Pleurectomy/Decortication (P/D):''' UCLA's signature procedure, removing the diseased pleural lining while preserving the lung
	* '''Extended Pleurectomy/Decortication:''' More extensive tissue removal when indicated, still sparing the lung		* '''Extended Pleurectomy/Decortication:''' More extensive tissue removal when indicated, still sparing the lung
	* '''Cytoreductive Surgery with HIPEC:''' For peritoneal mesothelioma patients, combining surgery with heated intraoperative chemotherapy		* '''Cytoreductive Surgery with HIPEC:''' For [[Peritoneal Mesothelioma\|peritoneal mesothelioma]] patients, combining surgery with heated intraoperative chemotherapy

	'''Medical Oncology'''		'''Medical Oncology'''
Line 135:		Line 135:
	* Immunotherapy with checkpoint inhibitors (nivolumab, ipilimumab, pembrolizumab)		* Immunotherapy with checkpoint inhibitors (nivolumab, ipilimumab, pembrolizumab)
	* Targeted therapies based on tumor molecular profiling		* Targeted therapies based on tumor molecular profiling
	* Participation in cutting-edge clinical trials		* Participation in cutting-edge [[Clinical Trials\|clinical trials]]

	'''Radiation Therapy'''		'''Radiation Therapy'''
Line 180:		Line 180:
	The West Los Angeles VA Medical Center, located at 11301 Wilshire Boulevard, Los Angeles, provides mesothelioma patients with access to UCLA's specialized expertise through an established collaboration.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Dr. Cameron and other UCLA specialists have treated veterans with mesothelioma through this partnership for years.		The West Los Angeles VA Medical Center, located at 11301 Wilshire Boulevard, Los Angeles, provides mesothelioma patients with access to UCLA's specialized expertise through an established collaboration.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Dr. Cameron and other UCLA specialists have treated veterans with mesothelioma through this partnership for years.

	'''VA Benefits for Mesothelioma Patients'''		'''[[VA Benefits]] for Mesothelioma Patients'''

	Veterans diagnosed with mesothelioma may be eligible for:		Veterans diagnosed with mesothelioma may be eligible for:

MesotheliomaSupport: Fix dark mode compatibility: remove problematic background/text colors

2026-01-29T14:29:30Z

Fix dark mode compatibility: remove problematic background/text colors

MesotheliomaSupport: Bot edit

2026-01-28T22:33:32Z

Bot edit

← Older revision		Revision as of 22:33, 28 January 2026
Line 4:		Line 4:
	\|keywords=UCLA mesothelioma, UCLA cancer center, Robert Cameron mesothelioma, lung-sparing surgery, pleurectomy decortication, Los Angeles mesothelioma treatment		\|keywords=UCLA mesothelioma, UCLA cancer center, Robert Cameron mesothelioma, lung-sparing surgery, pleurectomy decortication, Los Angeles mesothelioma treatment
	\|image=ucla-mesothelioma-program.jpg		\|image=ucla-mesothelioma-program.jpg
	\|author=~~Paul Danziger, Founding Partner,~~ Danziger & De Llano		\|author=Danziger & De Llano Legal Team
	\|published_time=2026-01-14		\|published_time=2026-01-14
	}}		}}
Line 36:		Line 36:
	== Executive Summary ==		== Executive Summary ==

	The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://~~dandell~~.~~com~~/~~mesothelioma/mesothelioma~~-~~diagnosis~~/~~mesothelioma~~-cancer-~~guide~~-2/ Mesothelioma ~~Cancer Guide~~], ~~Danziger & De Llano~~</ref>		The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma at UCLA Health], UCLA Health</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

	Dr. Cameron's development of the pleurectomy/decortication technique challenged the prevailing wisdom of his era, which favored complete lung removal. His approach—treating mesothelioma as a chronic illness requiring ongoing management rather than attempting cure through aggressive surgery—has influenced treatment protocols nationwide.

	The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> ~~In October 2023, the program welcomed Dr. Bryan Burt as Chief of Thoracic Surgery, bringing NIH-funded immunotherapy research from his previous role at Baylor College of Medicine.~~ Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

	~~<div style="clear:both;"></div~~>

	== Key Facts ==		== Key Facts ==
Line 307:		Line 301:
	* Coordinate legal efforts with your medical treatment		* Coordinate legal efforts with your medical treatment

	{~~\| style="width:100%; background:#1a5276; border-radius:8px; margin:1em 0;"~~		{{CTA Box}}
	\|-
	~~\| style="padding:20px; text-align:center; color:white;" \|~~
	~~'''📞 Call Today: (866) 222-9990'''~~

	~~Free Consultation • No Upfront Costs • Se Habla Español~~

	~~[https://dandell.com/contact-us/ Request Your Free Case Review Online]~~
	\|}

	== References ==		== References ==

MesotheliomaSupport at 06:04, 15 January 2026

2026-01-15T06:04:56Z

← Older revision		Revision as of 06:04, 15 January 2026
Line 4:		Line 4:
	\|keywords=UCLA mesothelioma, UCLA cancer center, Robert Cameron mesothelioma, lung-sparing surgery, pleurectomy decortication, Los Angeles mesothelioma treatment		\|keywords=UCLA mesothelioma, UCLA cancer center, Robert Cameron mesothelioma, lung-sparing surgery, pleurectomy decortication, Los Angeles mesothelioma treatment
	\|image=ucla-mesothelioma-program.jpg		\|image=ucla-mesothelioma-program.jpg
	\|author=Danziger & De Llano ~~Legal Team~~		\|author=Paul Danziger, Founding Partner, Danziger & De Llano
	\|published_time=2026-01-14		\|published_time=2026-01-14
	}}		}}

MesotheliomaSupport: /* Key Facts */

2026-01-15T05:55:50Z

Key Facts

← Older revision		Revision as of 05:55, 15 January 2026
Line 41:		Line 41:

	The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> In October 2023, the program welcomed Dr. Bryan Burt as Chief of Thoracic Surgery, bringing NIH-funded immunotherapy research from his previous role at Baylor College of Medicine. Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>		The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> In October 2023, the program welcomed Dr. Bryan Burt as Chief of Thoracic Surgery, bringing NIH-funded immunotherapy research from his previous role at Baylor College of Medicine. Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

			<div style="clear:both;"></div>

	== Key Facts ==		== Key Facts ==

MesotheliomaSupport: /* Executive Summary */

2026-01-15T05:54:22Z

Executive Summary

← Older revision		Revision as of 05:54, 15 January 2026
Line 36:		Line 36:
	== Executive Summary ==		== Executive Summary ==

	The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://dandell.com/mesothelioma/mesothelioma-diagnosis/mesothelioma-cancer-guide-2/ Mesothelioma Cancer Guide], Danziger & De Llano</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>		The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://dandell.com/mesothelioma/mesothelioma-diagnosis/mesothelioma-cancer-guide-2/ Mesothelioma Cancer Guide], Danziger & De Llano</ref>

			Dr. Cameron's development of the pleurectomy/decortication technique challenged the prevailing wisdom of his era, which favored complete lung removal. His approach—treating mesothelioma as a chronic illness requiring ongoing management rather than attempting cure through aggressive surgery—has influenced treatment protocols nationwide.

			The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> In October 2023, the program welcomed Dr. Bryan Burt as Chief of Thoracic Surgery, bringing NIH-funded immunotherapy research from his previous role at Baylor College of Medicine. Patients seeking treatment at UCLA can also pursue legal compensation for their asbestos exposure through trust funds and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

	== Key Facts ==		== Key Facts ==

MesotheliomaSupport: Updated UCLA Mesothelioma Program content

2026-01-15T05:51:55Z

Updated UCLA Mesothelioma Program content

Show changes

MesotheliomaSupport: Created page with "Coming Soon"

2026-01-15T05:50:50Z

Created page with "Coming Soon"

New page

Coming Soon

← Older revision		Revision as of 20:56, 20 February 2026
Line 36:		Line 36:
	== Executive Summary ==		== Executive Summary ==

	The UCLA Comprehensive Mesothelioma Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma at UCLA Health], UCLA Health</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their [[Asbestos Exposure\|asbestos exposure]] through [[Trust Funds\|trust funds]] and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>		The UCLA Comprehensive [[Mesothelioma]] Program holds the distinction of being the first formally dedicated mesothelioma treatment program established in the United States, founded in 1997 by thoracic surgeon Dr. Robert Brian Cameron.<ref>[https://mesothelioma.net/ucla-jonsson-comprehensive-cancer-center/ UCLA Jonsson Comprehensive Cancer Center], Mesothelioma.net</ref> Operating within the UCLA Jonsson Comprehensive Cancer Center—which earned NCI comprehensive designation in 1976—the program pioneered a lung-sparing surgical philosophy that offered patients an alternative to more radical procedures.<ref>[https://www.uclahealth.org/medical-services/lung-cancer/conditions-we-treat/mesothelioma Mesothelioma at UCLA Health], UCLA Health</ref> The program maintains a significant partnership with the West Los Angeles VA Medical Center, providing specialized care to veterans who comprise approximately 30% of all mesothelioma patients nationwide.<ref>[https://mesothelioma.net/va-west-los-angeles-medical-center-los-angeles-california/ VA West Los Angeles Medical Center], Mesothelioma.net</ref> Patients seeking treatment at UCLA can also pursue legal compensation for their [[Asbestos Exposure\|asbestos exposure]] through [[Trust Funds\|trust funds]] and other recovery options.<ref>[https://www.mesotheliomalawyercenter.org/veterans/ Veterans Mesothelioma Cases], Mesothelioma Lawyer Center</ref>

	== Key Facts ==		== Key Facts ==
Line 165:		Line 165:

	'''MEDI4736 Studies:'''		'''MEDI4736 Studies:'''
	Trials examining durvalumab alone or combined with tremelimumab in surgically resectable malignant pleural mesothelioma.		Trials examining durvalumab alone or combined with tremelimumab in surgically resectable malignant [[Pleural Mesothelioma\|pleural mesothelioma]].

	{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"
Line 239:		Line 239:
	'''Asbestos [[Trust Funds]]'''		'''Asbestos [[Trust Funds]]'''

	Over $30 billion remains available in 60+ asbestos bankruptcy trust funds established by companies that manufactured or used asbestos products.<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], Mesothelioma Attorney</ref> Many patients qualify for multiple trusts based on their exposure history:		Over $30 billion remains available in 60+ asbestos bankruptcy [[Trust Funds\|trust funds]] established by companies that manufactured or used asbestos products.<ref>[https://mesotheliomaattorney.com/mesothelioma/trust-funds/ Mesothelioma Trust Funds], Mesothelioma Attorney</ref> Many patients qualify for multiple trusts based on their exposure history:

	* '''Average Trust Fund Payment:''' $300,000 - $400,000 total		* '''Average Trust Fund Payment:''' $300,000 - $400,000 total
Line 249:		Line 249:
	Beyond trust funds, mesothelioma patients may pursue:<ref>[https://www.mesotheliomalawyercenter.org/asbestos-lawyer/ Asbestos Lawyers], Mesothelioma Lawyer Center</ref>		Beyond trust funds, mesothelioma patients may pursue:<ref>[https://www.mesotheliomalawyercenter.org/asbestos-lawyer/ Asbestos Lawyers], Mesothelioma Lawyer Center</ref>

	* '''Personal Injury Lawsuits:''' Against companies responsible for asbestos exposure		* '''Personal Injury Lawsuits:''' Against companies responsible for [[Asbestos Exposure\|asbestos exposure]]
	* '''Wrongful Death Claims:''' For families who have lost loved ones		* '''Wrongful Death Claims:''' For families who have lost loved ones
	* '''Settlement Negotiations:''' Often faster than going to trial		* '''Settlement Negotiations:''' Often faster than going to trial
	* '''VA Benefits:''' For veterans (can be pursued simultaneously with legal claims)		* '''[[VA Benefits]]:''' For veterans (can be pursued simultaneously with legal claims)

	{\| style="width:100%; border:1px solid #ffc107; border-left:5px solid #ffc107; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #ffc107; border-left:5px solid #ffc107; border-radius:4px; margin:1em 0;"

← Older revision		Revision as of 14:29, 29 January 2026
Line 7:		Line 7:
	\|published_time=2026-01-14		\|published_time=2026-01-14
	}}		}}
	{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276~~; background:#ffffff~~; border-radius:8px; overflow:hidden;"		{\| class="infobox" style="width:280px; float:right; margin:0 0 1em 1em; border:2px solid #1a5276; border-radius:8px; overflow:hidden;"
	\|-		\|-
	! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA Mesothelioma Program		! colspan="2" style="background:#1a5276; color:white; padding:12px; font-size:1.1em; text-align:center;" \| UCLA Mesothelioma Program
	\|-		\|-
	\| colspan="2" style="~~background:#e8f4f8;~~ padding:10px; text-align:center; font-style:italic~~; color:#333333~~;" \| First dedicated U.S. mesothelioma program		\| colspan="2" style="padding:10px; text-align:center; font-style:italic; " \| First dedicated U.S. mesothelioma program
	\|-		\|-
	\| style="padding:10px; font-weight:bold; width:40%~~; background:#f8f9fa~~; border-bottom:1px solid #dee2e6~~; color:#333333~~;" \| Founded		\| style="padding:10px; font-weight:bold; width:40%; border-bottom:1px solid #dee2e6; " \| Founded
	\| style="padding:10px; border-bottom:1px solid #dee2e6~~; background:#ffffff; color:#333333~~;" \| 1997		\| style="padding:10px; border-bottom:1px solid #dee2e6; " \| 1997
	\|-		\|-
	\| style="padding:10px; font-weight:bold~~; background:#f8f9fa~~; border-bottom:1px solid #dee2e6~~; color:#333333~~;" \| Location		\| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6; " \| Location
	\| style="padding:10px; border-bottom:1px solid #dee2e6~~; background:#ffffff; color:#333333~~;" \| Los Angeles, CA		\| style="padding:10px; border-bottom:1px solid #dee2e6; " \| Los Angeles, CA
	\|-		\|-
	\| style="padding:10px; font-weight:bold~~; background:#f8f9fa~~; border-bottom:1px solid #dee2e6~~; color:#333333~~;" \| NCI Designation		\| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6; " \| NCI Designation
	\| style="padding:10px; border-bottom:1px solid #dee2e6~~; background:#ffffff; color:#333333~~;" \| Comprehensive (1976)		\| style="padding:10px; border-bottom:1px solid #dee2e6; " \| Comprehensive (1976)
	\|-		\|-
	\| style="padding:10px; font-weight:bold~~; background:#f8f9fa~~; border-bottom:1px solid #dee2e6~~; color:#333333~~;" \| Founder		\| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6; " \| Founder
	\| style="padding:10px; border-bottom:1px solid #dee2e6~~; background:#ffffff; color:#333333~~;" \| Dr. Robert Cameron		\| style="padding:10px; border-bottom:1px solid #dee2e6; " \| Dr. Robert Cameron
	\|-		\|-
	\| style="padding:10px; font-weight:bold~~; background:#f8f9fa~~; border-bottom:1px solid #dee2e6~~; color:#333333~~;" \| Specialization		\| style="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6; " \| Specialization
	\| style="padding:10px; border-bottom:1px solid #dee2e6~~; background:#ffffff; color:#333333~~;" \| Lung-Sparing Surgery		\| style="padding:10px; border-bottom:1px solid #dee2e6; " \| Lung-Sparing Surgery
	\|-		\|-
	\| style="padding:10px; font-weight:bold~~; background:#f8f9fa; color:#333333~~;" \| VA Partnership		\| style="padding:10px; font-weight:bold; " \| VA Partnership
	\| style="padding:10px~~; background:#ffffff; color:#333333~~;" \| West LA VA Medical Center		\| style="padding:10px; " \| West LA VA Medical Center
	\|-		\|-
	\| colspan="2" style="background:#1a5276; padding:10px; text-align:center;" \| [https://dandell.com/contact-us/ <span style="color:white; font-weight:bold;">🛡️ Free Case Review →</span>]		\| colspan="2" style="background:#1a5276; padding:10px; text-align:center;" \| [https://dandell.com/contact-us/ <span style="color:white; font-weight:bold;">🛡️ Free Case Review →</span>]
Line 43:		Line 43:
	! style="background:#1a5276; color:white; padding:12px; text-align:left;" \| Key Facts: UCLA Comprehensive Mesothelioma Program		! style="background:#1a5276; color:white; padding:12px; text-align:left;" \| Key Facts: UCLA Comprehensive Mesothelioma Program
	\|-		\|-
	\| style="padding:15px~~; background:#f8f9fa; color:#333333~~;" \|		\| style="padding:15px; " \|
	* '''Program Founded:''' 1997 — first dedicated mesothelioma program in the United States		* '''Program Founded:''' 1997 — first dedicated mesothelioma program in the United States
	* '''Cancer Center NCI Designation:''' Comprehensive Cancer Center since 1976		* '''Cancer Center NCI Designation:''' Comprehensive Cancer Center since 1976
Line 72:		Line 72:
	At a time when extrapleural pneumonectomy (EPP)—complete removal of the affected lung along with surrounding tissues—dominated mesothelioma surgery, Dr. Cameron championed an alternative philosophy. He pioneered and refined the pleurectomy/decortication (P/D) procedure, which removes diseased tissue while preserving the lung itself.<ref>[https://dandell.com/mesothelioma-lawyer/california/los-angeles/ Los Angeles Mesothelioma Lawyer], Danziger & De Llano</ref>		At a time when extrapleural pneumonectomy (EPP)—complete removal of the affected lung along with surrounding tissues—dominated mesothelioma surgery, Dr. Cameron championed an alternative philosophy. He pioneered and refined the pleurectomy/decortication (P/D) procedure, which removes diseased tissue while preserving the lung itself.<ref>[https://dandell.com/mesothelioma-lawyer/california/los-angeles/ Los Angeles Mesothelioma Lawyer], Danziger & De Llano</ref>

	{\| style="width:95%; margin:1em auto~~; background:#f8f9fa~~; border-left:4px solid #1a5276; border-radius:4px;"		{\| style="width:95%; margin:1em auto; border-left:4px solid #1a5276; border-radius:4px;"
	\|-		\|-
	\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5~~; color:#333333~~;" \| "We've observed that patients who retain their lung function often tolerate subsequent treatments better and maintain a higher quality of life throughout their care journey."		\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5; " \| "We've observed that patients who retain their lung function often tolerate subsequent treatments better and maintain a higher quality of life throughout their care journey."
	\|-		\|-
	\| style="padding:5px 25px 20px; text-align:right~~; color:#333333~~;" \| '''— Paul Danziger,''' Founding Partner, Danziger & De Llano		\| style="padding:5px 25px 20px; text-align:right; " \| '''— Paul Danziger,''' Founding Partner, Danziger & De Llano
	\|}		\|}

Line 115:		Line 115:
	Dr. Burt's research focuses on response and resistance mechanisms to immunotherapy in thoracic malignancies. In 2021, he received a $2.5 million grant from the National Cancer Institute to fund ongoing biomarker testing to determine which pleural mesothelioma patients would benefit from immunotherapy.		Dr. Burt's research focuses on response and resistance mechanisms to immunotherapy in thoracic malignancies. In 2021, he received a $2.5 million grant from the National Cancer Institute to fund ongoing biomarker testing to determine which pleural mesothelioma patients would benefit from immunotherapy.

	{\| style="width:100%~~; background:#cce5ff~~; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #007bff; border-left:5px solid #007bff; border-radius:4px; margin:1em 0;"
	\|-		\|-
	\| style="padding:15px~~; color:#004085~~;" \| '''ℹ️ Research Breakthrough:''' In 2022, Dr. Burt's research combining cytokine factories and immune checkpoint inhibitors demonstrated complete eradication of late-stage mesothelioma tumors in mice within days—one of the most promising laboratory results ever achieved for this disease.		\| style="padding:15px; " \| '''ℹ️ Research Breakthrough:''' In 2022, Dr. Burt's research combining cytokine factories and immune checkpoint inhibitors demonstrated complete eradication of late-stage mesothelioma tumors in mice within days—one of the most promising laboratory results ever achieved for this disease.
	\|}		\|}

Line 167:		Line 167:
	Trials examining durvalumab alone or combined with tremelimumab in surgically resectable malignant pleural mesothelioma.		Trials examining durvalumab alone or combined with tremelimumab in surgically resectable malignant pleural mesothelioma.

	{\| style="width:100%~~; background:#d4edda~~; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #28a745; border-left:5px solid #28a745; border-radius:4px; margin:1em 0;"
	\|-		\|-
	\| style="padding:15px~~; color:#155724~~;" \| '''✓ Clinical Trial Access:''' UCLA patients have opportunities to participate in cutting-edge research that may provide access to tomorrow's standard treatments today. Ask your care team about eligibility for current trials.		\| style="padding:15px; " \| '''✓ Clinical Trial Access:''' UCLA patients have opportunities to participate in cutting-edge research that may provide access to tomorrow's standard treatments today. Ask your care team about eligibility for current trials.
	\|}		\|}

Line 189:		Line 189:
	* '''Aid and Attendance Benefits:''' For veterans requiring assistance with daily activities		* '''Aid and Attendance Benefits:''' For veterans requiring assistance with daily activities

	{\| style="width:95%; margin:1em auto~~; background:#f8f9fa~~; border-left:4px solid #1a5276; border-radius:4px;"		{\| style="width:95%; margin:1em auto; border-left:4px solid #1a5276; border-radius:4px;"
	\|-		\|-
	\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5~~; color:#333333~~;" \| "Veterans often don't realize they can pursue both VA benefits and legal compensation simultaneously. These are separate systems, and qualifying for one doesn't affect eligibility for the other."		\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5; " \| "Veterans often don't realize they can pursue both VA benefits and legal compensation simultaneously. These are separate systems, and qualifying for one doesn't affect eligibility for the other."
	\|-		\|-
	\| style="padding:5px 25px 20px; text-align:right~~; color:#333333~~;" \| '''— Rod De Llano,''' Founding Partner, Danziger & De Llano		\| style="padding:5px 25px 20px; text-align:right; " \| '''— Rod De Llano,''' Founding Partner, Danziger & De Llano
	\|}		\|}

Line 254:		Line 254:
	* '''VA Benefits:''' For veterans (can be pursued simultaneously with legal claims)		* '''VA Benefits:''' For veterans (can be pursued simultaneously with legal claims)

	{\| style="width:100%~~; background:#fff3cd~~; border:1px solid #ffc107; border-left:5px solid #ffc107; border-radius:4px; margin:1em 0;"		{\| style="width:100%; border:1px solid #ffc107; border-left:5px solid #ffc107; border-radius:4px; margin:1em 0;"
	\|-		\|-
	\| style="padding:15px~~; color:#856404~~;" \| '''⚠️ Important:''' California has specific statutes of limitations for asbestos claims. The time to file may be limited from the date of diagnosis. Consulting with an experienced mesothelioma attorney promptly can help protect your legal rights.		\| style="padding:15px; " \| '''⚠️ Important:''' California has specific statutes of limitations for asbestos claims. The time to file may be limited from the date of diagnosis. Consulting with an experienced mesothelioma attorney promptly can help protect your legal rights.
	\|}		\|}

Line 281:		Line 281:
	* Comprehensive treatment records supporting damages claims		* Comprehensive treatment records supporting damages claims

	{\| style="width:95%; margin:1em auto~~; background:#f8f9fa~~; border-left:4px solid #1a5276; border-radius:4px;"		{\| style="width:95%; margin:1em auto; border-left:4px solid #1a5276; border-radius:4px;"
	\|-		\|-
	\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5~~; color:#333333~~;" \| "The exposure history that physicians document during treatment often reveals companies and products that patients didn't even realize contained asbestos. This information can significantly expand compensation recovery."		\| style="padding:15px 20px 10px; font-style:italic; font-size:1.05em; line-height:1.5; " \| "The exposure history that physicians document during treatment often reveals companies and products that patients didn't even realize contained asbestos. This information can significantly expand compensation recovery."
	\|-		\|-
	\| style="padding:5px 25px 20px; text-align:right~~; color:#333333~~;" \| '''— Paul Danziger,''' Founding Partner, Danziger & De Llano		\| style="padding:5px 25px 20px; text-align:right; " \| '''— Paul Danziger,''' Founding Partner, Danziger & De Llano
	\|}		\|}